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1 Introduction
The proposal for the structure of the DNA double helix in
19531 is generally considered to be the point at which genetic
phenomena started to be understandable in molecular and
chemical terms. Indeed Watson and Crick were themselves
directly dependent for their success on the chemical knowledge
of nucleotides from the work of Todd and his school, as well
as relying heavily on X-ray crystallographic studies of
nucleobases and nucleosides.2
The Watson–Crick structure is a model based on the fibre-
diVraction data of Franklin and Wilkins. As such, it represents
a low-resolution structure averaged over all sequences and
conformations. More detailed descriptions of DNA structure,
and of its wide variability, had to await the availability of pure
quantities of defined oligonucleotide sequences in the 1970s.
These have enabled single crystals of a wide range of
DNA (and now RNA) structural types to be obtained and
their structures solved, in a large part without recourse to
any assumptions about particular models. In addition, the
crystal structures of a large number of biologically-relevant
drug–nucleic acid and protein–nucleic acid complexes have
now been solved. The latter is an area of especially rapid
growth, and will not be discussed here.3 This review will survey
the significant crystal structures of nucleic acids and their drug
complexes published over the past few years, which have seen
an exponential growth in the oligonucleotide structures
reported in the literature. The attention of readers is drawn
to the comprehensive and up-to-date compilation of all these
nucleic acid single-crystal structures in the Nucleic Acid
Database,4 with 618 entries as of February 1997. Background
information on nucleic acid structures, together with reviews
on such topics as fibre diVraction from polynucleotides and
NMR studies in solution, is available elsewhere.5–8
As with all crystal structures, considerations of accuracy
and reliability are important when analysing and comparing
structures. Nucleic acid structures are generally not at atomic
resolution, with 2.0–2.5 Å being typical. This means that their
crystallographic refinement requires the use of constraints
and restraints on geometry and conformation. Refinement
procedures themselves, as well as the individual geometric
parameters used, have significantly changed over the past few
years, which aVects any detailed comparison of structures.9
The X-PLOR program10 is now almost universally the choice
for all nucleic acid-containing structures, involving the use of
an empirical force-field. This is generally considered to be
well-parameterised for nucleic acid duplexes, but may not be
adequate for the increasing number of structures with non-
standard base–base interactions and folds, especially of RNA
molecules. Extra parameters are invariably required for nucleic
acid–drug complexes; however these are rarely available in the
primary literature so it is not straightforward to assess the
validity of such parameterisations.
2 DNA native duplexes
2.1 B-DNA structures—DNA close to the physiological state?
Fibre-diVraction studies of helical natural and synthetic poly-
nucleotides have characterised their structures in terms of
precisely-repetitious mono- or di-nucleotide units, with only
small variations being observed with particular sequences. The
structure of the first fully base-paired full turn of double helix
to be determined by single-crystal methods,11 using multiple
isomorphous phasing, was that of the sequence d(CGCGAAT
TCGCG), at 1.9 Å resolution. This structure shows, by con-
trast, a number of sequence-dependent features, such as a
narrow minor groove in the AT region, high propeller twists
for the A·T base pairs and considerable variation in base
and base-step helical parameters such as helical twist and
roll. These features are sensitive to the protocols used in
the crystallographic refinement,12 which further underlines the
inadvisability of deriving general conclusions about the
detailed features of sequence-dependent DNA structure from
one of even a few crystal structures. The AT region of the
minor groove in d(CGCGAATTCGCG) was found to contain
an ordered array of water molecules, the ‘spine of hydration’,
whose existence has more recently been confirmed by NMR
spectroscopic13 and simulation14 studies. There is an increas-
ing realisation of the importance of structured water
molecules, not only in stabilising particular aspects of DNA
(and RNA) structure, but in acting as probes for nucleic acid
recognition.15
A large number of variants16 of this dodecamer sequence,
mostly with small changes in the central 4–6 base pairs, have
subsequently been analysed. Almost all crystallise in the same
space group (P212121), with interdigitation of adjacent helices
in the crystal lattice and involvement of the terminal two base
pairs at each end of an individual duplex. The fact that the
central 6–8 base pair region in this packing arrangement is
unaVected by adjacent molecules in the lattice, suggests that it
is suitable for systematic studies of features occurring in this
region, such as base mismatches and drug binding.17 It can be
argued that the dodecamer duplex is less suitable, at least on its
own, for comparative studies of sequence-dependent features,
since ideally one would wish to observe a particular sequence
type in more than one crystallographic context in order for
Neidle and Nunn: Crystal structures of nucleic acids and their drug complexes 1
Pu
bl
ish
ed
 o
n 
01
 Ja
nu
ar
y 
19
98
. D
ow
nl
oa
de
d 
by
 L
O
N
D
O
N
 M
ET
RO
PO
LI
TA
N
 U
N
IV
ER
SI
TY
 o
n 
03
/0
8/
20
15
 1
4:
04
:1
1.
 
View Article Online / Journal Homepage / Table of Contents for this issue
lattice packing eVects to be minimised.18 An initial result of
surveys which included decamer as well as dodecamer struc-
tures (see below) was the finding that there appears to be
considerable variability in the geometries of many base steps
and individual short sequences, and therefore that a search for
sequence-dependent features is pursuing an illusory goal. It has
even been suggested that the variations in structural features
merely represent distortions arising from crystal packing
forces. However a more realistic interpretation is that the
variability observed for many features in these B-DNA struc-
tures, are real eVects, and represent their degrees of flexibility.
Analysis of structure and conformation for ensembles of
structures via the Nucleic Acid Database is an eVective
approach. It has been used to show19 that phosphodiester
backbone torsion angles in the higher resolution sub-set of
B-DNA oligonucleotide structures cluster in discrete regions.
The majority of these have been previously noted in studies
of individual structures, but several new clusters are now
apparent, which suggest hitherto unsuspected structural
correlations and modes of concerted flexibility between
backbone torsion angles.
2.1.1 DNA bending
The dodecamer duplexes reported to date (apart from those
involving mismatches or bound drug), are almost all of the
type d(CGCX6GCG), where X6 is an AT-containing sequence,
and where the overall sequence is self-complementary.
Structures with runs of both alternating and non-alternating
A·T base pairs have been reported. The structure20 of the
non-self-complementary sequence d(CGCGAAAAAACG),
crystallised with the sequence d(CGTTTTTTCGCG), is of
particular interest. It is non-isomorphous with almost all other
dodecanucleotide structures, even though it is still in the same
space group (P212121). The extended AT tract has typically
narrow minor groove and high propeller-twisted A·T base
pairs. The helix has an overall bend of 30) in the major groove
direction, which is somewhat distinct from the bending
towards the major groove observed in the crystal structures of
the various members of the d(CGCGAATTCGCG) duplex
family. All of these crystal structures appear to diVer from the
phased bending of A-tracts in solution, usually within rather
longer sequences, in which bending has been inferred to occur
towards the minor groove direction.21
The definition of bending in molecular terms for DNA
containing A-tracts, continues to be controversial. The con-
trast in interpretations from solution and crystallographic
studies has been ascribed to the eVects of the hydrophobic
alcohols such as 2-methylpentane-2,4-diol (MPD) commonly
used in the crystallisation of oligonucleotides.22 It has been
suggested that MPD has the ability to markedly decrease DNA
curvature, in accord with its eVect of reducing the anomalous
behaviour of A-tract DNA in gel retardation experiments. This
interpretation has been challenged in a comprehensive study23
of all the crystal structures which show bending, where it is
pointed out that, even though MPD does indeed have some
eVect on bending, it does not involve simple dehydration
around the DNA, and moreover does not actually shed any
light on the molecular basis of the phenomenon. There is no
correlation between the degree of bending observed in the
crystal, and the MPD concentration. These authors conclude
that the crystallographic observations are consistent with
bending occurring outside the A-tracts themselves, which
remain straight. The details of the structural changes at these
interface sequences have been suggested by several crystal
structures,24–26 although none with true phased A-tract
sequences have as yet have been reported.
A comparative study27 of four oligonucleotide crystal
structures, combined with gel retardation experiments, has
provided further support for A-tract models with a narrow
minor groove, high propeller twist for the A·T base pairs,
cross-strand major groove bifurcated hydrogen bonds. In all
these structures, the A-tract itself is straight, with bending at
the flanking sequences. It is clear that there is no unique
direction of the bending, and DNA sequences will deform in
ways that are dictated by environment and the nature of the
molecules with which it interacts. This is shown on the one
hand by the consistent bending towards major groove
directions shown by the oligonucleotide crystal structures,
indicating that this mode of bending is accessible to even the
comparatively lattice forces in a crystalline environment. On
the other hand, it is typical for the DNA in protein–DNA
complexes27 to bend in the minor groove direction, suggesting
that this type of bending requires the greater enthalpy of
interaction with a protein. An extreme example of DNA
bending has been observed in oligonucleotide complexes with
the TATA-box binding protein,28 where the DNA is bent
by ca. 80), but now towards the major groove. This is
accompanied by unwinding so that the DNA most aVected
assumes a non-B-DNA A-like conformation, which can be
modelled by simple deformations involving local conformation
changes.29
2.1.2 Sequence-dependent DNA structure
The relevance of crystal structures of native oligonucleotides
containing gene-regulatory protein recognition sequences, to
the structures of the protein–DNA complexes, has been
demonstrated in several studies. The crystal structure30 of the
trp operator/repressor complex incorporates the six base-pair
recognition site d(ACTAGT). The crystal structure31 of the
native decanucleotide duplex d(CCACTAGTGG), shows
features of structure and hydration directly analogous to those
in the protein complex. For example, the depth and contours
of the major groove are similar for this sequence in both native
and protein-bound states, as is the pattern of base hydration.
Ten hydration sites in the major groove are conserved in the
two states; the three which mediate critical protein–DNA
contacts also have conserved hydrogen-bonding geometries. It
is suggested that these features are intrinsic to this particular
DNA sequence. On the other hand, a study32 of a constituent
of this sequence, the tetranucleotide d(CTAG), which occurs in
both the trp and met repressor–operator complexes, has shown
that when compared with its structure in the native sequence
d(CTCTAGAG), its conformation is somewhat variable. This
variability is most pronounced at the central TpA step.
The implication of these comparative studies is that the
details of conformation, helical parameters and hydration at
particular sequences, as seen in native oligonucleotide crystal
structures, can have relevance to the situations in protein
complexes. However the relationship between sequence and
structure is complex, and still only imperfectly understood at
the native DNA level, in spite of much eVort over the past
15 years. There have been a large number of studies which
have attempted to correlate sequence-dependent structural
features in native oligonucleotide structures. This initially
focused on the ten distinct dinucleotide steps, but as an
increasing number of oligonucleotide structures have been
determined, it has been realised that the essential minimal unit
of structure description is the tetranucleotide sequence, of
which there are 134 variants.33, 34 Even at the dinucleotide
level, it is apparent that only some XpY steps show consistent
behaviour. This has been observed where a particular sequence
has been crystallised in more than one packing arrangement.
For example, the sequence d(CCAACITTGG) (where I is the
non-natural nucleoside inosine) occurs in both monoclinic and
trigonal space groups.35 The helical twists at the CpA and TpG
dinucleotide steps are nearly 15) greater for the monoclinic
structure. The TpA step has also been found to have a variable
geometry, as observed36 in two structures [of d(CGCTAGCG)
and d(CGCTCTAGAGCG)].
These observations of variability in structural features
have been interpreted as being due to crystal packing eVects,
although there is little evidence to demonstrate this for
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particular runs of sequence. Rather, these observations are
showing the inherent flexibility of some dinucleotide and
tetranucleotide steps, which when observed in diVerent
structures, are sampled at diverse points on their broad energy
surfaces. This interpretation suggests that consideration of the
available ensemble of structures, as has been done for back-
bone torsion angles,18 could provide a fuller picture of the
flexibility available to the diVerent steps in an oligonucleotide.
An examination37, 38 of 60 native structures, on the basis solely
of the ten dinucleotide steps, has derived an overall kinematic
classification involving base-pair slide, roll and helical twist.
This analysis has confirmed and extended predictions made
on the basis of empirical force-field calculations.39 These
emphasise,40 on the one hand, the importance of electrostatic
contributions to those relative motions of bases (shift and
slide) which retain them parallel to each other, and on the
other, van der Waals interactions which primarily contribute
to those motions (such as roll, tilt and slide) which do not
retain base parallelism. A comparative analysis of dinucleotide
steps is valid since, with the exception of the under-represented
ApG step, the available database of structures is now suY-
ciently representative of all nine other steps for statistically
meaningful conclusions to be drawn. However, it should be
borne in mind that such an analysis necessarily ignores nearest-
neighbour and longer-range eVects, since few of the 134
tetranucleotide steps are represented in the oligonucleotide
database. The available evidence is that these eVects (for
example, the influence of an adjacent A-tract) can sometimes
dominate structure at a particular sequence locus.41
2.1.3 Non-standard B-DNA structures
The crystal packing motifs of many B-DNA oligonucleotides
involves either the end-to-end stacking of helices (many
decanucleotide structures) or the inter-digitating of the ends of
helices (in almost all dodecanucleotide structures). A notable
sub-class of the former has the end-to-end helices packed not
in side-by-side parallel arrangements with respect to each
other, but inclined at 40–60) to form crossed helices. This motif
has been recognised as being a model for four-way junctions
envisaged to occur during genetic recombination. It involves
groove–backbone intermolecular close contacts42 (Fig. 1),
involving the major groove of one helix and phosphate groups
from another.43 Molecular modelling has been used to
generate plausible four-way junctions models from these
structures.44 The sequence d(CGCAATTGCG) forms distinct
crystal structures, dependent on environmental conditions.
One is of a fully base-paired decamer duplex,44 whereas the
other has the 3* and 5* terminal nucleotides swung out from
the helix and hydrogen bonding in the grooves of symmetry-
related duplexes.45 The crystal structure of the non-self-
complementary decamer sequence d(CGACGATCGT) shows
a helical octamer duplex stem formed by d(ACGATCGT) and
its complement, together with a 5*-d(CG) sticky end.46
2.2 A-DNA structures
The A polymorph of double-helical DNA was identified
in early fibre-diVraction studies, as being formed under
conditions of low relative humidity. A-type structures are
characterised by having base pairs inclined with respect to
the helix axis and significantly displaced from it, thus changing
the dimensions of both major and minor grooves compared
to B-type structures. The biological significance of the A family
of DNA structures continues to be controversial. The deter-
mination of the structure of the TATA-box protein–DNA
complex, which has shown that deforming a region of a
B-DNA structure into an A form produces a widened minor
groove and an overall bend of the DNA.28, 29 This suggests a
role in protein-induced bending, and that A-type structures are
most likely to exist when forced to by external factors such as
crystal packing or protein binding. It is striking that no NMR
studies of native DNA duplexes have revealed the existence
of the A form in solution, i.e. when removed from these
factors.
The A family has been observed in numerous crystal
structures of self-complementary octanucleotides, most likely
as a consequence of specific crystal packing constraints,47–49 as
well as in a number of decanucleotides with a high proportion
of C·G base pairs. Considerable variability, in particular, in
groove width, has been observed in these structures. The
packing motifs of A-DNA oligonucleotides invariably involve
interdigitation of the terminal base pairs from one duplex into
the minor groove of an adjacent one in the lattice. The
importance of crystallographic studies on this family of oligo-
nucleotides is that they provide insight into the range of
structures, and hence the flexibility of the A-type structural
class, which in turn illuminates the mechanisms whereby some
gene-regulatory proteins deform DNA.
Several polymorphic crystal structures of d(CCGGGC
CCGG)50 and two cytosine-methylated analogues have been
determined, all of which require the polycationic amine
spermine for crystallisation, and the more compact show
ordered spermine molecules in the crystal structures. In com-
mon with the A-DNA octamer crystal structures, conforma-
tions of most of these polymorphs diVer significantly from that
of classic fibre-diVraction A-DNA. For the three polymorphs
of d(CCGGCC5meCGG), the number of residues per complete
turn of helix ranges from 10.7 to 11.6, and the average
inclination of base pairs to the helix axis ranges from 10.7 to
18.2). The hydration of A-DNA structures has been found to
Fig. 1 Groove–backbone interactions in the crystal structure of the
DNA decamer d(CGCAATTGCG) (ref. 44)
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be sequence-dependent,51 and the superior hydration of CpG
base pairs compared to TpA correlates with diVerences in
helical twist and base-pair roll.52
The sequence d(AGGCATGCCT) forms an unprecedented
structure,53 with the central eight nucleotides base-pairing with
a symmetry-related strand to form an A-form octamer duplex.
The terminal bases are swung away from this short helix to
form A·T base pairs with other symmetry-related molecules,
forming an overall infinite chain-like arrangement.
3 DNA base-mismatched structures at the duplex level
DNA bases can be covalently modified by the alkylating eVects
of a wide range of chemicals. The resulting base lesions are
mutagenic, and can ultimately produce cell transformation and
cancer, if they are not correctly repaired by cellular repair
enzymes. The recognition of lesions by these enzymes is likely
to be based on the structural diVerences resulting from them. A
number of crystal structures have examined DNA sequences
with guanine methylated at the O6 position, a consequence
of exposure to carcinogenic agents such as N-nitroso-N-
methylurea and N-methyl-N-nitrosoguanidine.
(O6Me)Guanine· · ·cytosine base pairing has been observed
in a left-handed Z-DNA structure,54 with standard Watson–
Crick rather than wobble-type hydrogen bonding between the
aVected bases (Fig. 2). This arrangement can only occur if
there is protonation of the guanine or the cytosine, or if one or
other is in a non-standard tautomeric state. It is likely that this
is a consequence of the particular base-stacking requirements
in Z-DNA, which would not favour a wobble arrangement
that would have the methylated guanine partially unstacked
and protruding into the major groove.
The O6 methylation event results in GC]AT transition
mutations, and thus the formation of a O6G· · ·T base pair
during replication. The structures of two dodecanucleotide
duplexes containing this mismatch have been reported.55, 56
The base pairing in both is analogous to the normal Watson–
Crick arrangement (Fig. 3), whereas NMR solution studies57
have suggested that the N1G· · ·N3T hydrogen bond is absent
or very weak. The origin of this diVerence is not clear, other
than that it may reflect diVerences between crystal and solution
environments.
4 Base triplets and triple-helical nucleic acids
It has long been known that a third nucleic acid strand
comprising pyrimidines can associate with a stretch of duplex
consisting of purines on one strand and pyrimidines on the
other, to form a triple helix.57 This parallel triple helix involves
Hoogsteen hydrogen-bonded base triplets of the form T–A·T
and C+–G·C, and can be either inter- or intra-molecular. In
both instances, the third strand occupies the major groove of
the initial duplex. The stringent sequence requirements of triple
helix formation are currently being explored for the artificial
down-regulation of the expression of particular genes,
ultimately for therapeutic purposes.58 The structural details of
DNA triple helices remain elusive; fibre diVraction studies
have only been at low resolution and have been interpreted in
terms of both A- and B-type conformations. No single-crystal
structure of a pure DNA triple helix is as yet available, in spite
of much eVort in a number of laboratories. The structure of a
mixed DNA–peptide nucleic acid (PNA) has been reported.59
It has a standard DNA purine strand together with PNA
sequences forming the two pyrimidine strands having a
hexapeptide linking them in a hairpin-like manner (Fig. 4). The
resulting triple helix (Fig. 5) has helical features of both A- and
B-DNA, with bases approximately perpendicular to the helix
axis (i.e. B form) yet significantly displaced from it (i.e. A
form). It is not clear to what extent features such as the very
wide major groove, reflect the non-nucleic acid nature of the
PNA backbone. A short two-triplet stretch of C+–G·C triplets
have been observed in a drug–decanucleotide crystal structure
where the terminal nucleosides do not form part of the duplex
but interact with neighbouring duplexes in the lattice, to form
this triplet.60
Anti-parallel triple helices can be formed with third-strand
purines and involve, for example, G–G·C base triplets. Again,
there is no crystal structure of such a triple helix. The
triplet base arrangements have been observed in several crystal
structures of duplexes with over-hanging ends [d(GCGAAT
TCG)61, 62 and d(GGCAATTGG)63], or with mismatches
[d(GGCAATTGCG)].64 In all instances the triplets are formed
by intermolecular hydrogen bonding of bases.
5 DNA quadruplexes
The richness of possibilities for DNA structures is seen at its
most striking for sequences containing either runs of either
G,T or C,A nucleotides. These sequences are of considerable
biological importance in view of their occurrence as repeated
sequences, predominantly at the ends of chromosomes, form-
ing so-called telomeres. Telomeric sequences can form a
variety of four-stranded structures, all of which necessarily
contain non-standard base-pairings.
Fig. 2 The (O6Me)G·C base pair (ref. 54)
Fig. 3 The (O6Me)G·T base-pair in the crystal structure of the
d[CGTGAATTC(O6Me)GCG]2 duplex (ref. 55)
Watson–Crick
base-pairing
+H3N C T C T T C T T C
3′–G A G A A G A A G–5′
–OOC C T C T T C T T C
His
Gly
Ser
Hoogsteen
base-pairing His
Gly
Ser
Fig. 4 Schematic view of the PNA:DNA triplex (ref. 59)
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The cytosine-rich sequences form four-stranded intercalated
complexes.65 That formed by the sequence d(CCCT) is typical,
with two parallel-stranded duplexes intercalated into each
other (Fig. 6), and the arrangement as a whole being formed by
four d(CCCT) strands.66 Each duplex has cytosine· · ·cytosine
base pairs (Fig. 7), with one of them required to be protonated
(even though crystallisations were successful at pH 6 or even
7). The thymines do not actively participate in the duplexes,
although some of them are stacked onto the ends. The cytosine
rings are not directly stacked on top of one another. Instead,
amino and carbonyl substituent groups form stacks, separated
by 3.1 Å rather than the normal 3.4 Å in oligonucleotide
helices. The same arrangement of intercalated cytosine
duplexes has been observed in the structure67 of the sequence
d(TAACCC), corresponding to the human telomere repeat.
The structure has four strands associating together so as to
produce an intercalated four-stranded structure, still with
parallel cytosine duplexes, but now with the 5* terminal
d(TAA) sequences forming intermolecular loops held together
by A· · ·T base pairings (Fig. 8). One of these has a Hoogsteen
arrangement, whilst the other shows reverse Watson–Crick
pairing. The crystal structure of the sequence d(CCCAAT) has
the intercalation motif extended by adenine· · ·adenine base
pairs as part of the arrangement of parallel duplexes. The
3* terminal thymines participate in a variety of intermolecular
A·A·T base triplets, which serve to stabilise the crystal
structure.
Although these C-rich sequences all appear to occur in
telomeres within duplexes (in contrast to the G-rich repeats—
see below), the fact that stable four-stranded structures
can be formed by them with individual short sequences,
suggests that if biological C-rich sequences became looped-out
of the duplex they might then be stabilised by an intra-
molecular four-stranded arrangement. Such loops could occur
as a result of negative supercoiling.
The G-rich single strand of telomeres has repetitive
sequences of the type d(TTTTGGGG)n (in Oxytricha),
d(TGGG)n (in budding yeast) and d(TTAGGG)n (in Homo
sapiens). Four-stranded structures can be formed in a variety
of ways, by intramolecular folding of several consecutive
repeats, by intermolecular association of four strands or by a
combination of both.68 The crystal structure69 of the sequence
d(GGGGTTTTGGGG) shows a stack of sets of the G-quartet
motif (Fig. 9), four guanine bases hydrogen-bonded to-
gether in one plane (Fig. 10). The four thymines form loops
between the stacks, as shown. A subsequent NMR spec-
troscopy study70 has reported a diVerent arrangement for the
four strands, whilst retaining the same arrangement of stacked
G-quartets.
The structure of the sequence d(TGGGGT) has been deter-
mined at 0.95 Å resolution,71 the highest resolution to date of
any nucleic acid structure. It consists of four individual strands
associated by means of a stack of four G-quartets. Sodium
ions stabilise the structure, between and within the G-quartets.
An unconventional four-stranded structure is formed72 by the
sequence d(GCATGCT), with two strands associating together
Fig. 5 The crystal structure of the PNA:DNA triplex (ref. 59)
Fig. 6 The four-stranded intercalated structure formed by d(CCCT)
(ref. 66)
Fig. 7 A C+·C base pair, of the type found within the C-rich quadru-
plex structures
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(Fig. 11), each folding back so that two quartets of (CG)2 are
formed. This structure suggests that quartet-type structures
may be more prevalent than hitherto supposed, since there is
no longer a restriction on quartets to solely contain guanines.
6 RNA and DNA–RNA hybrid structures
Early X-ray crystallographic investigations into RNA struc-
ture in the 1970s were concerned, on the one hand, with
transfer RNA73 and on the other with dinucleoside mono-
phosphate mini-helices both with and without bound drug
molecules.74 These short helices form right-handed antiparallel
duplexes with an A-form conformation.
Investigations into RNA structure over the last few years
has accelerated to produce a plethora of new and exciting
structures. This results in a large part from recent develop-
ments in RNA synthesis, both chemical and enzymatic, which
allows for the production of large quantities of high-quality
RNA for crystallisation studies. Specific RNA sequences can
now be synthesised, crystallised and their three-dimensional
structures determined.75 This section will survey recent X-ray
crystallographic structural studies on them. In addition to pure
RNA structures RNA–DNA hybrids will also be discussed.
6.1 RNA duplex structures
The octamer duplex r(CCCCGGGG) has been crystallised in
both rhombohedral and hexagonal lattices.76 There is little
diVerence between the two diVerent crystal forms. When
compared with the structure of the DNA sequence d(CCCCG
GGG)77 the RNA is seen to be more extensively hydrated than
the analogous DNA sequence with the ribose 2*-hydroxy
groups propagating stable and conserved water networks in
both grooves of the RNA duplex.
Crystallographic studies of ribosomal RNA are still in their
infancy. The E. coli Shine–Dalgarno consensus ribosome bind-
ing site r(UAAGGAGGUGAU):r(AUCACCUCCUUA) has
Fig. 8 The crystal structure of the four-stranded intercalated structure
formed by d(TAACCC) (ref. 67)
Fig. 9 The crystal structure of d(GGGGTTTTGGGG) (ref. 69)
N
NH
N
N
O
NH2
N
HN
N
N
O
H2N
N
H
N
N
N
O
NH2
N
N
H
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Fig. 10 The hydrogen-bonding arrangement in the guanine quadruplex
Fig. 11 The crystal structure of d(GCATGCT) (ref. 72)
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been found to form a duplex structure with Watson–Crick
base-pairing interactions along its length.78 Two unique
duplexes for this sequence show very similar conformations
and both resemble calf thymus A-DNA as found from X-ray
fibre diVraction studies. X-Ray crystallographic studies for the
entire 5S rRNA from the thermophilic bacterium Thermus
flavus79 have only produced crystals to date which exhibit very
poor resolution quality (8 Å). By subdividing the entire 5S
ribosomal RNA into subunits it has been possible to obtain
good-quality diVracting crystals. 5S Ribosomal RNA has been
subdivided into five subdomains A–E. Subdomain A com-
prises two RNA strands which form a double helix involving
Watson–Crick base-pairing interactions in addition to being
stabilised by two U·G and G·U base-pairs.80 Domain E of
Thermus flavus 5S rRNA contains the very stable and highly
conserved 5*-GCGA tetraloop. Crystallisation and preliminary
diVraction studies have been reported81 on it and structure
determination is underway.
The structure of the self-complementary tetradecamer
sequence r[U(UA)6A] is an A-type duplex with two kinks
along its length.82 The kink angles are 8.5 and 13.8) with an
overall angle between the two distal ends of the duplex of
21.7).
The structure of r(UUCGCG)83 has a central (CGCG)2
duplex formed by two RNA strands with an overhang of the
5*-UU bases from each strand. These overhanging uracil bases
interact with the overhang from a symmetry-related duplex
within the unit cell to form novel Hoogsteen-like U·U base-
pairs (Fig. 12). There is one hydrogen bond between atoms O4
and N3 of two uracil bases, while there is a second, less
conventional hydrogen bond between C5–H and O4. This
base-pairing arrangement results in a trans U·U pair on
antiparallel strands in contrast to the usual cis base-pairs. It
diVers from that found in RNA dodecamer duplexes with
non-Watson–Crick base-pairs. The potential importance of
C–H· · ·O hydrogen bonding interactions in nucleic acid
structure has been discussed.84
6.2 Mismatches in RNA structures
In addition to the U·U base-pairing interactions which
exist within the structure of r(UUCGCG),83 base-pairing
mismatches have been observed in a number of other RNA
structures [Fig. 13(a)–(e)]. Mismatched regions in RNA struc-
ture are a common secondary structural motif and termed
internal loops. These loop regions act as potential protein
recognition sites. The structure of r(GGCGCUUGCGUC)85
contains tandem U·U base-pairs within a dodecamer duplex in
addition to two G·U mismatches. As a result, the duplex has
an overall bend of 11–12). The structure of r(GGACUUUGG
UCC)86 similarly contains tandem U·U base pairs. The cis
U·U wobble pairs observed in both of these structures have
two hydrogen bonds, with potential sites for the binding of
water molecules in the major and minor grooves. Both also
contain, in addition to U·U base pairs, two G·U pairs along
the length of the dodecamer duplexes. In the case of
r(GGACUUUGGUCC) there is a run of four mismatched
base pairs.
The structure of r(GGACUUCGGUCC)87 has G·U and
C·U mismatches in the central third of the structure. The
structure has a central two-fold symmetry axis and two unique
mismatches. The G·U mismatch is stabilised by a solvent
molecule in the minor groove which also interacts with the
ribose hydroxy group. The structure of r(CGCGAAUUA
GCG)88 has two separated G·A mismatches within the
dodecamer duplex structure. The structure of r(GGCCGAA
AGGCC)89 has an internal loop with G·A and A·A
mismatches. Again the dodecamer duplex has a two-fold
symmetry axis, with two unique mismatches. The G·A
mismatches in this structure involve reverse Hoogsteen hydro-
gen bonding and have been termed sheared G·A base-pairs.
Both G·A and A·A base-pairs are very common in internal
loops of RNAs, including ribosomal RNA and ribozymes.
This structure has a 34) end-to-end curvature for the helix and
its diameter is narrowed by 24% in the internal loop.
The large number of structures of non-self-complementary
RNA sequences forming duplex structures with mismatched
base-pairs has resulted from attempts to crystallise RNA
sequences which have the potential to form stem-loop struc-
tures. Studies using NMR spectroscopy for such sequences
have shown them to form hairpin structures under the
conditions used. However under the conditions required for
the crystallisation of these sequences there is a preference for
duplex RNA to be formed.
6.3 RNA as an enzyme
Certain RNA sequences, termed ribozymes, have the ability to
either cleave other RNA molecules, or to self-cleave, by means
of a catalytic mechanism. The best studied ones are the
hammerhead ribozymes, which consist of three double helical
regions joined by 15 highly conserved nucleotides. These 15
central nucleotides are essential for ribozyme activity and
form a complex structure which mediates RNA folding and
catalysis. Hammerhead ribozymes comprise two strands, one
corresponding to the ‘enzyme’ and the other to the ‘substrate’.
A divalent metal ion such as Mg2+ is required by the ribozyme
to mediate catalytic cleavage of an RNA species.
Two crystallographic studies for hammerhead ribozymes
(Fig. 14) have been carried out. The first structure reported has
an RNA ‘enzyme’ strand and a DNA ‘substrate’ strand.90 The
DNA strand was employed in order to prevent catalytic
cleavage. The second hammerhead ribozyme structure
(Fig. 15) is composed entirely of RNA with a single 2*-methoxy
group modification at the active site to prevent cleavage.91 The
two structures have very similar structures for the catalytic
core region and results from these two structural studies
have led to proposals for the mechanism of RNA-cleavage
catalysis.92, 93
In addition to the two hammerhead ribozyme structures the
crystal structure of a self-splicing Group I ribozyme domain
has been recently determined.94 This 160 nucleotide P4–P6
domain from the Tetrahymena group I intron has been
reported to a resolution of 2.8 Å. The structure consists of two
extended helical regions that pack side by side with long-
range interactions between them. These interactions involve
an A-rich bulge of one helix and the minor groove of
another, together with a GAAA tetraloop at the end of one
helix and a tetraloop receptor in the minor groove of the other.
This structure has close packing of the ribose–phosphate
backbones, which is mediated by hydrated magnesium ions.
6.4 RNA–DNA hybrid structures
Short stretches of RNA–DNA hybrid structures are formed
during both replication and transcription, and are important in
antisense therapeutic applications where a deoxyoligonucleo-
tide sequence is targeted to a mRNA. One RNA–DNA hybrid
crystal structure determined to date is left-handed and of
Z-type,95 while the remainder are all right-handed. This hybrid
consists of alternating purine and pyrimidine bases
Fig. 12 U·U base-pair in the crystal structure of r(UUCGCG) (ref. 83)
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d(CG)r(CG)d(CG) and assumes the conformation seen for
all DNA sequences of this type. The octameric sequence
r(GUAUAUA)d(C)96 has a 3*-terminal deoxycytidine residue
at the end of a heptamer RNA sequence. This structure forms
a right-handed A-form double helix. The structure of the two
octamer sequences d(I)r(C)d(ICICIC) and d(I)r(C)d(I)r(C)
d(ICIC) have both been determined bound to the minor
groove binding drug distamycin A.97 These structures adopt a
B-form structure with two distamycin A molecules lying within
the minor groove of the B-form duplex (see below for a further
discussion of these two structures). These are the first examples
of RNA duplexes adopting the B-form family of helices, which
have been considered to be less stable for RNA compared to
DNA. The presence of drug binding may induce the transition
from A to B form in this structure which would suggest that
upon protein binding both duplex RNA and RNA–DNA
chimeric structures may be able to access a B form confor-
mation if required.
The nonamer sequence r(GCUUCGGC)dBrU forms an
octamer duplex structure98 with two diVerent types of base
Fig. 13 Mismatched base-pairs in dodecamer duplex RNA structures: (a) r(CGCGAAUUAGCG), (b) r(GGACUUCGGUCC), (c) r(GGACUU
UGGUCC), (d ) r(GGCCGAAAGGCC) and (e) r(GGCGCUUGCGUC)
8 Natural Product Reports, 1998
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mismatches. It has a G·U base pair with wobble hydrogen
bonding, while the C·U mismatch involves just one hydrogen
bonded contact, in addition to a bridging water molecule. The
terminal BrU-3* bases pair with another BrU via interactions
involving two hydrogen bonds.
A number of decamer chimeric (i.e. RNA and DNA residues
in the same strand) structures have been reported. The struc-
ture of r(GCG)d(TATACGC) is of an A-type decamer
duplex.99 The three decamer structures d(GGGTATACGC)/
r(GCG)d(TATACCC) (which is an Okazaki fragment), r(G)d-
(CGTATACGC) and d(GCGT)r(A)d(TACGC)100 all assume
A-type duplex conformations. For d(GGGTATACGC)/
r(GCG)d(TATACCC) there is no diVerence in backbone
conformation between the r(GCG)·d(CGC) portion of the
structure and the d(TATACCC)·d(GGGTATA) all-DNA
helical region. The three decamer structures d(CCGGC)r(G)
d(CCGG),101 r(C)d(CGGCGCCG)r(G)102 and r(GC)d(GTAT
ACGC),103 with one or two ribose bases along the decamer
length, all adopt an A-type conformation. One structure of a
DNA duplex with a 2*-O-methylribonucleotide insert104 has
been reported.
The decamer sequence r(UUCGGGCGCC)/d(GGCGCCC
GAA)105 is specifically recognised by the ribonuclease H
function of HIV reverse transcriptase. The structure of this
sequence has neither an A- or B-type conformation but
instead has characteristics of both. The structure of r(GCG)
d(ATATA)r(CGC) has been determined in two diVerent
crystal forms.106 This structure (Fig. 16) contains a single
adenosine bulge—a common secondary structural motif in
RNA.
7 Drug–nucleic acid structures
A wide range of drugs are known to exert their biological
eVects by means of interactions with cellular nucleic acids,
especially with chromosomal DNA.107–108 The majority are
anticancer agents, but antibacterial, antiviral, antifungal and
antiparasitic activities have also been found for some of them.
The DNA sequence selectivities shown by most of these drugs
is usually modest, and even those which covalently bind to
particular bases have selectivity for only short runs of
sequence. Thus the biological selectivities shown, for example
by the clinically-useful anthracycline anticancer drugs, cannot
be solely ascribed to DNA binding. There is increasing
evidence that interference with particular protein–DNA inter-
actions is critical for biological activity.109–111 For example,
the anthracyclines and related drugs have been shown to
stabilise the cleavable complex between DNA and the enzyme
DNA topoisomerase II. A number of covalent and non-
covalent DNA minor-groove agents compete with transcrip-
tion factors, and so interfere with gene regulation. There is as
Fig. 14 Schematic representation of the two hammerhead ribozyme
structures (refs. 90 and 91)
Fig. 15 The crystal structure of the all-RNA hammerhead ribozyme
(ref. 91). The two RNA strands are shown in diVerent colours
Fig. 16 The crystal structure of r(GCG)d(ATATA)r(CGC) (ref. 106)
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yet no structural data on any drug–DNA–protein ternary
complex, raising the question of the relevance of structural
studies on drug–DNA complexes alone. It is reassuring that
these have been at least partly successful in rationalising
structure–activity behaviour, suggesting that the structures of
the binary complexes have at least some relevance to those of
ternary complexes.
Crystallographic studies have concentrated on the inter-
calative and minor-groove categories of complexes, with few
exceptions. Very few covalent complexes have been reported,
in spite of the biological and medicinal importance of drugs
such as mitomycin and the nitrogen mustards. The problems
associated with obtaining significant quantities of pure oligo-
nucleotide adducts of these drugs have been largely overcome,
as attested by the numerous NMR studies on them. The
experience in this and other laboratories points to the problem
being largely of diYculties in obtaining crystals suitable for
studies even at medium (ca. 2.5 Å) resolution.
7.1 Intercalation complexes
The first drug–DNA crystal structures to be determined were
of structurally-simple intercalating molecules, typified by the
acridine proflavine,74 bound to dinucleoside monophosphate
mini-duplexes. These structures showed the planar drug
chromophore sandwiched between the two base pairs of the
dinucleoside duplex, but were unable to address issues of
conformational change in a nucleic acid beyond the immediate
intercalation site. This has to some extent been addressed by
subsequent structural studies on a large number of complexes
involving the clinically-important anthracycline anticancer
drug daunomycin (Fig. 17) and many of its derivatives, all
complexed with hexanucleotide duplexes.112 As of May 1997,
there were 22 entries for anthracycline complexes in the
Nucleic Acid Database.4 Most crystallise in the tetragonal
space group P41212. In general, these structures have two drug
molecules bound per hexamer duplex, one each at the terminal
base-pair sites, and with the daunosamine sugars lying in the
minor groove. The semi-synthetic derivative idarubicin co-
crystallises with the sequence d(CGATCG) in the trigonal
space group P31. The resulting structure is essentially identical
to the tetragonal ones, with invariance in the orientation of
bound drug chromophore and in the drug–DNA hydrogen-
bond contacts being observed.113 A novel bis-daunomycin
(Fig. 18) has recently been designed and synthesised114 using
the established anthracycline-hexamer crystal structures as a
starting-point. The semi-rigid linker between the two anthra-
cycline chromophores was chosen so as to preserve the posi-
tion and orientation of each, as seen in these monomer
structures. The new compound bis-intercalates into duplex
DNA with high aYnity and shows promising ability in cyto-
toxicity studies to circumvent multi-drug resistance in tumour
cells. The crystal structure115 of the bis-daunomycin com-
pound complexed with the sequence d(CGTACG) (Fig. 19)
shows that many of the predictions are realised, with the linker
positioned in the minor groove of the hexamer duplex. It is
surprising that the linker appears to have very few close van
der Waals contacts with the groove surface, suggesting that
modifications to the structure of the linker might result in
further enhancements of DNA aYnity.
The related antitumour antibiotic nogalamycin (Fig. 17) also
preferentially intercalates at pyrimidine-3*,5*-purine sites, but
via a threading mechanism. Crystallographic studies, again on
hexanucleotide duplex complexes, have shown that this
anthracycline binds with the nogalose and aminoglucose
groups lying in the minor and major grooves, respectively
(Fig. 20). A complex with the sequence d(TGTACA) has
shown the drug bound in the two high-aYnity TpG sites,116
and highlights the contribution of solvent-mediated contacts to
the observed sequence selectivity of this drug. The complex
between nogalamycin and the sequence d(CCCGGG) is
notable117 in that it uniquely shows a 1:1 anthracycline–duplex
complex, with the one drug molecule bound at the central CpG
site (Fig. 20). The conformation of the unwound DNA has
features of both A- and B-type helices. This structure is thus
representative of anthracyclines bound in extended lengths of
DNA sequence.
Intercalation at the centre of extended sequences has also
been observed118 for the antitumour antibiotic actinomycin
(Fig. 21), showing this antitumour antibiotic bound at the
central GpC site of the sequence d(GAAGCTTC). The two
cyclic pentapeptide rings lie in the minor groove, and there is a
predicted set of hydrogen bonds from threonine residues to N2
atoms of the two central guanines. The same DNA sequence
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Fig. 18 The bis-daunomycin molecule (ref. 115)
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has also been cocrystallised with N8-actinomycin, where the
8-position in the phenoxazone ring has been replaced by a
nitrogen atom.119
The interactions of meso-substituted porphyrins with DNA
have been much studied. The crystal structure of the tetra-
pyridyl porphyrin TMPy with the sequence d(CGTACG)
shows120 that intercalation of the central planar porphyrin ring
system is accompanied by flipping-out of one nucleoside
from the intercalation site. This is not unexpected, given the
stringent steric requirements of the bulky porphyrin system
with respect to intercalation.
7.2 Groove-bound complexes
A large group of drugs bind non-covalently in the minor
groove of AT-rich regions of B form DNA duplexes. Struc-
tural studies have focused on the nature of this sequence
selectivity, which is currently being extensively exploited in the
design of analogues with selectivities for mixed-sequence
DNA.121–125 Particular use has been made of the self-
complementary dodecamer duplex sequences d(CGCXAATT
YGCG)2, where X=A or G and Y=T or C, since the central
regions are largely unaVected by intermolecular contacts in the
crystal, other than with water molecules. The pattern of
hydrogen bonding in these complexes has been systematically
examined.126
The crystal structures of a number of complexes with drugs
typified by pentamidine, berenil and their analogues, have been
reported.127–130 These have shown that hydrophobic interac-
tions with hydrogen atoms from the nucleotide backbone (H1*,
H4* and H5*, which line the walls of the minor groove), are in
large part responsible for the AT-selectivity of these drugs. The
minor groove is narrow at AT sequences and its width is close
to the cross-sectional diameter of these drugs. Hydrogen
bonding to A·T base-pair edges is, by contrast, relatively weak
and variable.
7.2.1 Complexes with Hoechst analogues
A second category130 of non-covalent minor-groove drugs,
typified by netropsin, distamycin and Hoechst 33258 (Fig. 22),
tend to have fixed patterns of hydrogen bonding to base pair
edges, to N3 of adenines and O2 of thymines. Thus the two
benzimidazole groups in Hoechst 33258 and its analogues
consistently form two bifurcated pairs of hydrogen bonds to
base edges (Fig. 23), extending over three base pairs in
total.131–133 The analogue with three linked benzimidazole
groups134 follows the same pattern of hydrogen bonding, with
now three pairs of hydrogen bonds, covering four A·T base
pairs. This ligand has an overall binding site of ca. 7.5 bases, so
that it covers three quarters of a complete turn of a B-DNA
double helix. In order for the three benzimidazole groups to be
in register (in phase) with the four successive A·T base pairs,
one end of the ligand is not in close van der Waals contact with
the floor of the minor groove, so that the ligand is overall not
isohelical with the contour of the groove.
The isohelicity principle135 is also seen to be violated in the
crystal structure of an amidinium analogue of Hoechst 33258
bound to d(CGCGAATTCGCG)2, where there is eVective
binding to DNA, yet with the drug not having a concave inner
curvature to match minor groove isohelicity.136 Here, the
dominance of hydrogen bonds from one amidinium group is
suYcient to overcome the usual requirement for eVective van
der Waals contacts along the length of the ligand. Altering AT
selectivity for GC by simple replacement of a hydrogen bond
Fig. 19 Crystal structure of a bis-daunomycin–d(CGTACG) complex
(ref. 115)
Fig. 20 Crystal structure of nogalamycin complexed with d(CCCGGG)
(ref. 117)
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Fig. 21 Actinomycin
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donor in the minor groove by an acceptor (for the N2 group
of guanine), has been shown to be ineVective in the case of
the meta-hydroxy analogue of Hoechst 33258, contrary to
theoretical predictions.137 The hydroxy group is positioned
insufficiently deeply into the groove for such an interaction to
occur, and the analogue is thus not able to actively recognise
G·C base pairs.
7.2.2 Complexes with netropsin and analogues
The antibiotic netropsin (from Streptomyces netropsis) is in
many ways the paradigm for minor groove binding drugs,
although several crystal structures have shown it bound in
subtly diVerent ways within AT sequences. A careful study138
has been made of optimal refinement and electron-density map
interpretation for the complex with d(CGCGAATTCGCG)2
has confirmed the original assignments of bifurcated hydrogen
bonds to the AT base pairs, analogous to those formed by the
benzimidazole drugs. That this result is not an artefact of
dodecamers was shown by the crystal structure60 of netropsin
bound to the decamer sequence d(CGCAATTGCG)2, where
the same pattern of drug–DNA hydrogen bonding was
observed as with the dodecamer complex. The lexitropsins
have been developed as netropsin analogues, where methyl-
pyrrole ring(s) have been replaced by methylimidazole rings
in order to attempt to switch recognition from AT to
GC sequences. As with the Hoechst analogue above, the
lexitropsins have not fulfilled these predictions, and a crystal
structure of a lexitropsin–dodecanucleotide complex139 shows
the methylimidazole ring to be lying in the AT region, as in
netropsin itself.
An alternative way of recognising GC sequences has been
developed, based on the observations from oligonucleotide
crystal structures, that such sequences tend to have a wide
minor groove. The ability of the monocationic antibiotic
distamycin to form side-by-side dimers in such regions, has
been the basis of fruitful studies on the design of ligands which
can select mixed DNA sequences with high aYnity and specifi-
city.123, 125 Several crystal structures have been reported for
distamycin complexes with sequences such as d(ICICICIC)140
and d(ICITACIT),141 as well as variants containing DNA/
RNA chimers.97 In all cases, two distamycin molecules are
bound per duplex (Fig. 24), which assumes a B-form structure,
with a minor groove widened to 7.8 Å to accommodate the two
drug molecules. Each distamycin hydrogen bonds to the
nearest strand, with backbone amide nitrogen atoms acting as
donors to thymine O2 and adenine N3 atoms, in a manner
analogous to the hydrogen seen in distamycin 1:2 complexes.
7.3 Covalent complexes
The crystal structures of only two covalently-linked drug–
DNA complexes involving significant lengths of oligonucleo-
tide, have been reported to date. That of the clinically-
important antitumour drug cis-platinum has the platinum
linked to N7 atoms of adjacent guanine bases in the sequence
d(CCTCTG*G*TCTCC):d(GGAGACCAGAGG), where G*
represents platinated guanine,142, 143 i.e. with cis-platinum
bound only on one strand. There are two duplexes in the
asymmetric unit, and both show significant bending at
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Fig. 22 Several groove-binding molecules
Fig. 23 Crystal structure of the complex between the DNA duplex
d(CGCGAATTGCGC) and a bis-benzimidazole compound (ref. 133)
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the platination site, of 26) towards the major groove side. The
minor groove is opened up, in a manner reminiscent of the
DNA bending observed in the structures of TFIIIA–DNA
complexes,27–29 with backbone geometry having features of
both A- and B-form DNA. It is suggested that the platinum-
induced bending of DNA could provide a signal for protein
binding, especially for those involved in DNA damage repair.
The antitumour antibiotic anthramycin (from Streptomyces
refuineus) binds covalently via the benzodiazepine ring, to the
N2 atom of guanine, with a preference for guanine flanked on
both sides by a purine. The complex with the decamer
d(CCAACGTTG*G) has two anthramycin molecules bound
per duplex144 (Fig. 25), with each lying in a narrowed region of
the minor groove. The sequence specificity is considered to
arise from lower twist angles at purine–purine steps, rather
than from hydrogen bonding to particular bases.
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